Groupe Novasep

Type: Company
Name: Groupe Novasep
Nationality: France
Web Address: http://www.novasep.com/
First reported Oct 09 2014 - Updated Oct 09 2014 - 1 reports

Novasep to Sell its Bahamian Plant to Local Investor

Company has completed the sale of the Bahamian facility and related business of its fully-owned subsidiary, Pharmachem. ... [Published Technology Networks - Oct 09 2014]
Entities: Groupe Novasep
First reported Oct 08 2014 - Updated Oct 08 2014 - 1 reports

Exploring the Challenges in Downstream Processing for Industrial Biotechnology - Presentations now available

On 25th September 2014, the IBLF's Downstream Processing for Industrial Biotechnology event took place hosted by CPI in Wilton, and supported by Adapt. The 80+ delegates heard presentations looking at the challenges faced by downstream processing and ... [Published Connect - Oct 08 2014]
First reported Oct 07 2014 - Updated Oct 07 2014 - 2 reports

Novasep to sell its Bahamian plant

07-10-2014: Novasep, a leading supplier of manufacturing solutions to the life sciences industry, announces that it has completed the sale of the Bahamian facility and related business of its fully-owned subsidiary, Pharmachem Technologies (Grand Bahama) ... [Published Bionity.com - Oct 07 2014]
First reported Oct 02 2014 - Updated Oct 02 2014 - 1 reports

Novasep To Sell Its Bahamian Plant To Local Investor

- Novasep, a leading supplier of manufacturing solutions to the life sciences industry, announces that it has completed the sale of the Bahamian facility and related business of its fully-owned subsidiary, Pharmachem Technologies (Grand Bahama) Ltd (Pharmachem), ... [Published BioSpace - Oct 02 2014]
First reported Sep 30 2014 - Updated Sep 30 2014 - 1 reports

Membrane Technology Market in Pharmaceutical, Biopharma and Life Sciences is Expected to reach USD 10,886.0 million in 2019

According to a new market report published by “Global Market Study on Membrane Technology in Pharmaceutical, Biopharma and Life Sciences: North America to Witness Highest Growth by 2019” the global membrane technology market for pharmaceutical, is estimated ... [Published MyNewsDesk - Sep 30 2014]
First reported Sep 29 2014 - Updated Sep 29 2014 - 1 reports

API Developers Note Upgrades, Successful Inspections

Lucidio Studio, Inc./In the first seven months of 2014, eight API manufacturers were issued warning letters by FDA due to infractions ranging from failure to maintain records; labeling and branding issues; failure to perform laboratory tests and maintain ... [Published PharmTech.com - Sep 29 2014]
First reported Sep 25 2014 - Updated Sep 25 2014 - 1 reports

Separation and purification, the missing link between biomass deconstruction and commercial product

Thibault Lesaffre from Novasep will present on ' ' at the Downstream Processing for Industrial Biotechnology event taking place today.Biomass is of extremely diverse nature. Transforming biomass through chemical or biochemical catalysts leads to mixtures ... [Published Connect - Sep 25 2014]
First reported Sep 22 2014 - Updated Sep 22 2014 - 1 reports

Global Membrane Technology Market in Pharmaceutical, Biopharma and Life Sciences Will Reach $10,886.0 million in 2019 - Persistence Market Research

According to a new market report published by “Global Market Study on Membrane Technology in Pharmaceutical, Biopharma and Life Sciences: North America to Witness Highest Growth by 2019” the global for pharmaceutical, biopharma and life sciences is estimated ... [Published MyNewsDesk - Sep 22 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

European Normal phase/hydrophilic interaction columns Market is Expected to Reach $17.4 million in 2018 - New Report by MicroMarket Monitor

The European normal phase/hydrophilic interaction columns report define and segment the concerned market in Europe with analysis and forecast of revenue. http://www.micromarketmonitor.com/market/europe-normal-phase-hydrophilic-interaction-columns-766 ... [Published Virtual Strategy Magazine - Sep 18 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 1 reports

What’s Next in Cell Culture & Upstream Processing?

This fall at BioProcess International , we have a track dedicated to Cell Culture & Upstream Processing.  When you join us to learn about this topic, find out more about proven approaches and technologies to reduce timelines and increase efficiency and ... [Published Future of BioPharma - Sep 16 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 1 reports

API Developers Pass Inspections and Upgrade Capabilities

Lucidio Studio, Inc./In the first seven months of 2014, eight API manufacturers were issued warning letters by FDA due to infractions ranging from failure to maintain records; labeling and branding issues; failure to perform laboratory tests and maintain ... [Published PharmTech.com - Sep 15 2014]
First reported Aug 14 2014 - Updated Aug 14 2014 - 1 reports

BIO Latin America Program Highlights

BIO Latin America is just one short month away, September 9-11 in Rio de Janeiro, Brazil, and with this in mind BIO has announced the preliminary program as well as an initial list of presenting companies. Program topics include: Regional Biotech ... [Published I Am Biotech - Aug 14 2014]

Quotes

Michel Spagnol, Chairman and CEO of Novasep, said: "The divestiture of Pharmachem is part of Novasep’s strategy to refocus on our core business and assets and to provide flexible and cost-effective CMO services to the life sciences industry. I am glad to say that the divestiture of this plant to a local investor is positive for both parties and Pharmachem’s employees."
Browse more than 94 market data tables with spread through 195 Slides and in-depth TOC on "Membrane Filtration Market”"

More Content

All (17) | News (13) | Reports (0) | Blogs (3) | Audio/Video (0) | Fact Sheets (1) | Press Releases (0)
sort by: Date | Relevance
Novasep to Sell its Bahamian Plant to Local Inv... [Published Technology Networks - Oct 09 2014]
Exploring the Challenges in Downstream Processi... [Published Connect - Oct 08 2014]
Novasep to sell its Bahamian plant [Published Bionity.com - Oct 07 2014]
Novasep to sell its Bahamian plant to local inv... [Published Manufacturing Chemist - Oct 07 2014]
Novasep To Sell Its Bahamian Plant To Local Inv... [Published BioSpace - Oct 02 2014]
Membrane Technology Market in Pharmaceutical, B... [Published MyNewsDesk - Sep 30 2014]
API Developers Note Upgrades, Successful Inspec... [Published PharmTech.com - Sep 29 2014]
Separation and purification, the missing link b... [Published Connect - Sep 25 2014]
HPAPIs and Cytotoxic Drugs Manufacturing Market... [Published Nation's Restaurant News - Sep 23 2014]
Global Membrane Technology Market in Pharmaceut... [Published MyNewsDesk - Sep 22 2014]
European Normal phase/hydrophilic interaction c... [Published Virtual Strategy Magazine - Sep 18 2014]
What’s Next in Cell Culture & Upstream Processing? [Published Future of BioPharma - Sep 16 2014]
API Developers Pass Inspections and Upgrade Cap... [Published PharmTech.com - Sep 15 2014]
BIO Latin America Program Highlights [Published I Am Biotech - Aug 14 2014]
BioProcess International Spotlight: Manufacturi... [Published Future of BioPharma - Jul 04 2014]
Membrane Filtration Market for Pharmaceutical W... [Published PRWeb - Apr 23 2014]
Fact Sheet for Rockwood Holdings, Inc. [Published Able2Act - Jan 08 2008]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
What’s Next in Cell Culture & Upstream Processing? [Published Future of BioPharma - Sep 16 2014]
This fall at BioProcess International , we have a track dedicated to Cell Culture & Upstream Processing.  When you join us to learn about this topic, find out more about proven approaches and technologies to reduce timelines and increase efficiency and ...
BIO Latin America Program Highlights [Published I Am Biotech - Aug 14 2014]
BIO Latin America is just one short month away, September 9-11 in Rio de Janeiro, Brazil, and with this in mind BIO has announced the preliminary program as well as an initial list of presenting companies. Program topics include: Regional Biotech ...
BioProcess International Spotlight: Manufacturi... [Published Future of BioPharma - Jul 04 2014]
Learn how to maximize your efficiencies and cost savings across your manufacturing network through the implementation of disruptive technologies, operational excellence and new facility concepts, while remaining flexible to the production needs of ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.